|
A more recent version of this article appeared on July 1, 2005
Papers In Press, published online ahead of print April 16, 2005
J. Lipid Res., doi:10.1194/jlr.M500085-JLR200
Submitted on March 1, 2005
Revised on March 28, 2005
Accepted on April 12, 2005
Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low-density lipoprotein receptor-deficient mice
Brian W. Parks, Ginger P. Gambill, Aldons J. Lusis, and Janusz H. S. Kabarowski
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294-2170
Corresponding Author: janusz{at}uab.edu
Lysophosphatidylcholine is considered a major pro-atherogenic component of oxidized low-density lipoprotein based on its pro-inflammatory actions in vitro. Lysophosphatidylcholine stimulates macrophage and T cell chemotaxis via the G protein-coupled receptor G2A and may thus promote inflammatory cell infiltration during atherosclerotic lesion development. However, G2A also mediates pro-apoptotic effects of lysophosphatidylcholine and may therefore promote death of inflammatory cells within developing lesions. To determine how these effects of lysophosphatidylcholine modify atherogenesis, we examined atherosclerotic lesion development in G2A-sufficient and G2A-deficient low-density lipoprotein receptor knockout mice. Although lysophosphatidylcholine species capable of activating G2A-dependent responses were increased during lesion development, G2A-deficient mice developed lesions similar in size to those in their G2A-sufficient counterparts. Loss of G2A during atherosclerotic lesion development did not reduce macrophage and T cell infiltration but instead resulted in increased lesional macrophage content associated with reduced numbers of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeled cells and decreased collagen deposition. These data indicate that the ability of lysophosphatidylcholine to stimulate macrophage and T cell chemotaxis via G2A is not manifested in vivo and G2A-mediated pro-apoptotic rather than chemotactic action is most penetrant during atherogenesis and may modify the stability of atherosclerotic lesions by promoting macrophage death.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Murakami, T. Hashidate, T. Harayama, T. Yokomizo, T. Shimizu, and M. Nakamura
Transcriptional regulation of human G2A in monocytes/ macrophages: involvement of c/EBPs, Runx and Pu.1
Genes Cells,
December 1, 2009;
14(12):
1441 - 1455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Parks, R. Srivastava, S. Yu, and J. H.S. Kabarowski
ApoE-Dependent Modulation of HDL and Atherosclerosis by G2A in LDL Receptor-Deficient Mice Independent of Bone Marrow-Derived Cells
Arterioscler Thromb Vasc Biol,
April 1, 2009;
29(4):
539 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Bolick, M. D. Skaflen, L. E. Johnson, S.-C. Kwon, D. Howatt, A. Daugherty, K. S. Ravichandran, and C. C. Hedrick
G2A Deficiency in Mice Promotes Macrophage Activation and Atherosclerosis
Circ. Res.,
February 13, 2009;
104(3):
318 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Frasch, K. Zemski-Berry, R. C. Murphy, N. Borregaard, P. M. Henson, and D. L. Bratton
Lysophospholipids of Different Classes Mobilize Neutrophil Secretory Vesicles and Induce Redundant Signaling through G2A
J. Immunol.,
May 15, 2007;
178(10):
6540 - 6548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Bolick, A. M. Whetzel, M. Skaflen, T. L. Deem, J. Lee, and C. C. Hedrick
Absence of the G Protein-Coupled Receptor G2A in Mice Promotes Monocyte/Endothelial Interactions in Aorta
Circ. Res.,
March 2, 2007;
100(4):
572 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Parks, A. J. Lusis, and J. H.S. Kabarowski
Loss of the Lysophosphatidylcholine Effector, G2A, Ameliorates Aortic Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
Arterioscler Thromb Vasc Biol,
December 1, 2006;
26(12):
2703 - 2709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Namgaladze and B. Brune
Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells
Arterioscler Thromb Vasc Biol,
November 1, 2006;
26(11):
2510 - 2516.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|